Zemcelpro Wins EC Approval as First Cell Therapy for Blood Cancer Patients Without Suitable Donors Read more
Pfizer and BioNTech’s COMIRNATY Gets FDA Approval for Seniors and High-Risk Individuals Ages 5-64 Read more